Cargando…
Statin discontinuation in persons with and without Alzheimer’s disease
BACKGROUND: Although statin use is reported to decrease after dementia diagnosis, time to statin discontinuation and factors associated with discontinuation have not been studied in persons with Alzheimer’s disease (AD). We compared the risk of discontinuation and factors associated with discontinua...
Autores principales: | Vu, Mai, Kettunen, Raimo, Tolppanen, Anna-Maija, Hartikainen, Sirpa, Taipale, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184400/ https://www.ncbi.nlm.nih.gov/pubmed/35449421 http://dx.doi.org/10.1007/s00228-022-03320-3 |
Ejemplares similares
-
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
por: Vallius, Sanna, et al.
Publicado: (2021) -
Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer’s Disease
por: Vu, Mai, et al.
Publicado: (2021) -
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009) -
Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease
por: Ali Babar, Barkat, et al.
Publicado: (2022) -
Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study
por: Sundvall, Helena, et al.
Publicado: (2022)